Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,062 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study.
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C. Oishi T, et al. Among authors: yamamoto h. Prostate. 2023 Feb;83(2):198-203. doi: 10.1002/pros.24453. Epub 2022 Oct 31. Prostate. 2023. PMID: 36314250
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.
Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C. Ozaki K, et al. Among authors: yamamoto h. World J Urol. 2023 Jan;41(1):67-75. doi: 10.1007/s00345-022-04237-3. Epub 2022 Dec 15. World J Urol. 2023. PMID: 36520204
Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers.
Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C. Togashi K, et al. Among authors: yamamoto h. Cancers (Basel). 2022 Dec 17;14(24):6229. doi: 10.3390/cancers14246229. Cancers (Basel). 2022. PMID: 36551713 Free PMC article.
Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer.
Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C. Fujita N, et al. Among authors: yamamoto h. PLoS One. 2023 Feb 10;18(2):e0275921. doi: 10.1371/journal.pone.0275921. eCollection 2023. PLoS One. 2023. PMID: 36763567 Free PMC article.
Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, Ishii N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C. Oishi T, et al. Among authors: yamamoto h. Sci Rep. 2023 Mar 1;13(1):3436. doi: 10.1038/s41598-023-30627-7. Sci Rep. 2023. PMID: 36859718 Free PMC article.
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C. Ozaki Y, et al. Among authors: yamamoto h. Transl Androl Urol. 2023 Feb 28;12(2):161-167. doi: 10.21037/tau-22-521. Epub 2023 Feb 6. Transl Androl Urol. 2023. PMID: 36915880 Free PMC article.
Relationship between lower urinary tract symptoms and frailty.
Ozaki Y, Hatakeyama S, Imai A, Songee J, Soma O, Ozaki K, Fujita N, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C. Ozaki Y, et al. Among authors: yamamoto h. Int J Urol. 2023 Jul;30(7):606-613. doi: 10.1111/iju.15187. Epub 2023 Apr 23. Int J Urol. 2023. PMID: 37087744
10,062 results
You have reached the last available page of results. Please see the User Guide for more information.